Product Information
CRYSELLE-28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2908 per EA under NDC 00555904958. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555904958
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075840On Market Since
7/24/2002
Price Statistics
The NADAC for CRYSELLE-28 TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 52.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2908 per EA |
|---|---|
| All-time high | $0.6139 (Nov 12, 2014) |
| All-time low | $0.2908 (Jun 17, 2026) |
| 52-week high | $0.3813 |
| 52-week low | $0.2908 |
| Median price | $0.4385 |
| Average price | $0.4449 |
| Largest weekly change | +27.0% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CRYSELLE-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CRYSELLE-28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2908 per EA (NDC 00555904958), effective Jun 24, 2026.
How has the price of CRYSELLE-28 TABLET changed over time?
Over the history we have for it, the NADAC for CRYSELLE-28 TABLET has declined 52.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CRYSELLE-28 TABLET?
Since Nov 28, 2013, the NADAC for CRYSELLE-28 TABLET has ranged from a low of $0.2908 (Jun 17, 2026) to a high of $0.6139 (Nov 12, 2014), with a median of $0.4385 per EA.
Are there cheaper alternatives to CRYSELLE-28 TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CRYSELLE-28 TABLET, but none are currently priced below it.
Who manufactures CRYSELLE-28 TABLET?
CRYSELLE-28 TABLET (NDC 00555904958) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification